Terkko Navigator / -/ Feeds / " ( ( Tyrosiini )|( Tyr )|( Tyrosinum )|( Parahydroksifenyylialaniini )|( L-tyrosiini )|( T"

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

Tyrosine phosphorylation of the scaffold protein IQGAP1 in the MET pathway alters function [Signal Transduction]

Tyrosine phosphorylation tunes chemical and thermal sensitivity of TRPV2 ion channel

Tyrosine phosphorylation tunes chemical and thermal sensitivity of TRPV2 ion channel

Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56 Lck regulates T-cell activation independently of Lck/CD45 interactions

Tyr is Responsible for the Cctq1a QTL and Links Developmental Environment to Central Corneal Thickness Determination

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome.

Tyrosine supplementation for phenylketonuria.

Tyrosine supplementation for phenylketonuria.

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown.

Tyrosine nitration of flagellins: a response of Sinorhizobium meliloti to nitrosative stress.

Tyrosine Phosphorylation of the Kv2.1 Channel Contributes to Injury in Brain Ischemia.

Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of humanα7 nicotinic acetylcholine receptor

Tyrosine-O-sulfation is a widespread affinity enhancer among thrombin interactors

Tyrosine phosphorylation of mitofusin 2 regulates endoplasmic reticulum-mitochondria tethering

Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.

Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.

[Tyrosine kinases as targets of cancer therapy: form disbelief to Lazarus responses].

Tyrosine phosphorylation directs TACE into extracellular vesicles via unconventional secretion.

Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on In Silico And 3D-Human Vascular Lung Model Studies

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Tyrosine-derived polycarbonate membrane in treating mandibular bone defects. An experimental study.

Tyrosine-derived polycarbonate membrane in treating mandibular bone defects. An experimental study.

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.

Tyrosine kinase Fyn promotes apoptosis after intracerebral hemorrhage in rats by activating Drp1 signaling.

Tyrosine kinase inhibitors and interferon-α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines.

Tyrosine phosphorylation directs TACE into extracellular vesicles via unconventional secretion

Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia